United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $805.7M
| Line Item | Value | % of Total |
|---|---|---|
| Stock Repurchases | $500.0M | 62.1% |
| Working Capital | $113.8M | 14.1% |
| Other | $700.0K | 0.1% |
| Net Cash Flow | $191.2M | 23.7% |